Rok Hrzic1, Tobias Vogt2,3,4, Fanny Janssen2,5, Helmut Brand1,3. 1. Department of International Health, Maastricht University, Care and Public Health Research Institute, CAPHRI, Maastricht, The Netherlands. 2. Population Research Centre, Faculty of Spatial Sciences, University of Groningen, Groningen, The Netherlands. 3. Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India. 4. Max Planck Institute for Demographic Research, Rostock, Germany. 5. Netherlands Interdisciplinary Demographic Institute - KNAW / University of Groningen, The Hague, The Netherlands.
Abstract
BACKGROUND: The high mortality rates in the European Union (EU) Member States that acceded in 2004 sparked political interest in mortality convergence. Whether mortality is converging in the EU remains unclear. We reviewed the literature on mortality convergence in the post-2004 EU territory as a whole. We also explored whether the study designs influenced the results and whether any determinants of mortality convergence had been empirically examined. METHODS: A systematic literature review was performed. Our search included scientific databases and the websites of international governmental institutions and European demographic research institutes. RESULTS: We uncovered 94 unique records and included seven studies that reported on 36 analyses. There was marked methodological heterogeneity, including in the convergence measures (beta and sigma convergence). All of the beta convergence analyses found narrowing mortality differentials, whereas most of the sigma convergence analyses found widening mortality differentials. The results are robust to the units of analysis and mortality and dispersion measures. Our results also suggest that there is a lack of evidence on the determinants of mortality convergence in the EU. CONCLUSIONS: There is general agreement that the EU regions and the Member States with high initial mortality rates improved the fastest, but this trend did not lead to overall mortality convergence in the EU. The harmonization of mortality convergence measures and research into determinants of mortality convergence are needed to support future EU cohesion policy. Policy-makers should consider supporting areas that have moderate but stagnant mortality rates, in addition to those with high mortality rates.
BACKGROUND: The high mortality rates in the European Union (EU) Member States that acceded in 2004 sparked political interest in mortality convergence. Whether mortality is converging in the EU remains unclear. We reviewed the literature on mortality convergence in the post-2004 EU territory as a whole. We also explored whether the study designs influenced the results and whether any determinants of mortality convergence had been empirically examined. METHODS: A systematic literature review was performed. Our search included scientific databases and the websites of international governmental institutions and European demographic research institutes. RESULTS: We uncovered 94 unique records and included seven studies that reported on 36 analyses. There was marked methodological heterogeneity, including in the convergence measures (beta and sigma convergence). All of the beta convergence analyses found narrowing mortality differentials, whereas most of the sigma convergence analyses found widening mortality differentials. The results are robust to the units of analysis and mortality and dispersion measures. Our results also suggest that there is a lack of evidence on the determinants of mortality convergence in the EU. CONCLUSIONS: There is general agreement that the EU regions and the Member States with high initial mortality rates improved the fastest, but this trend did not lead to overall mortality convergence in the EU. The harmonization of mortality convergence measures and research into determinants of mortality convergence are needed to support future EU cohesion policy. Policy-makers should consider supporting areas that have moderate but stagnant mortality rates, in addition to those with high mortality rates.
Authors: Marina Karanikolos; Philipa Mladovsky; Jonathan Cylus; Sarah Thomson; Sanjay Basu; David Stuckler; Johan P Mackenbach; Martin McKee Journal: Lancet Date: 2013-03-27 Impact factor: 79.321
Authors: Rasika Rampatige; Lene Mikkelsen; Bernardo Hernandez; Ian Riley; Alan D Lopez Journal: Bull World Health Organ Date: 2014-09-16 Impact factor: 9.408